miRNA-34a reduces neointima formation through inhibiting smooth muscle cell proliferation and migration

Journal of Molecular and Cellular Cardiology

Volumn 89, Issue , 2015, Pages 75-86

  Chen, Qishan ^a   Yang, Feng ^a   Guo, Meiqun ^a   Wen, Guanmei ^b   Zhang, Cheng ^b   Luong, Le Anh ^b   Zhu, Jianhua ^a   Xiao, Qingzhong ^b   Zhang, Li ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cell migration; Cell proliferation; MicroRNAs; MiRNA 34a; Neointima; Notch1; Post angioplasty restenosis; Vascular smooth muscle cells

Indexed keywords

MICRORNA 34A; NOTCH1 RECEPTOR; PROTEIN P53; MICRORNA; MIRN34 MICRORNA, MOUSE; NOTCH RECEPTOR;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY INJURY; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMORAL ARTERY; GENE EXPRESSION REGULATION; MOUSE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; C57BL MOUSE; CELL MOTION; GENETIC TRANSCRIPTION; GENETICS; INJURIES; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHENOTYPE; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOPTOSIS; BASE SEQUENCE; CELL MOVEMENT; CELL PROLIFERATION; FEMORAL ARTERY; GENE EXPRESSION REGULATION; MICE, INBRED C57BL; MICRORNAS; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; PHENOTYPE; RECEPTORS, NOTCH; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84952667166     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.10.017     Document Type: Article

References (84)

1. Ross R., Glomset J.A. Atherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science 1973, 180:1332-1339.
2. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
3. Liu M.W., Roubin G.S., King S.B. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation 1989, 79:1374-1387.
4. Ip J.H., Fuster V., Badimon L., Badimon J., Taubman M.B., Chesebro J.H. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J. Am. Coll. Cardiol. 1990, 15:1667-1687.
5. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
6. Albinsson S., Suarez Y., Skoura A., Offermanns S., Miano J.M., Sessa W.C. MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1118-1126.
7. Bonauer A., Boon R.A., Dimmeler S. Vascular microRNAs. Curr. Drug Targets 2010, 11:943-949.
8. Small E.M., Olson E.N. Pervasive roles of microRNAs in cardiovascular biology. Nature 2011, 469:336-342.
9. Albinsson S., Sessa W.C. Can microRNAs control vascular smooth muscle phenotypic modulation and the response to injury?. Physiol. Genomics 2011, 43:529-533.
10. Condorelli G., Latronico M.V., Cavarretta E. MicroRNAs in cardiovascular diseases: current knowledge and the road ahead. J. Am. Coll. Cardiol. 2014, 63:2177-2187.
11. Quiat D., Olson E.N. MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment. J. Clin. Invest. 2013, 123:11-18.
12. Zampetaki A., Mayr M. MicroRNAs in vascular and metabolic disease. Circ. Res. 2012, 110:508-522.
13. Chen J., Yin H., Jiang Y., Radhakrishnan S.K., Huang Z.P., Li J., Shi Z., Kilsdonk E.P., Gui Y., Wang D.Z., Zheng X.L. Induction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferation. Arterioscler. Thromb. Vasc. Biol. 2011, 31:368-375.
14. Ji R., Cheng Y., Yue J., Yang J., Liu X., Chen H., Dean D.B., Zhang C. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microrna in vascular neointimal lesion formation. Circ. Res. 2007, 100:1579-1588.
15. Wang M., Li W., Chang G.Q., Ye C.S., Ou J.S., Li X.X., Liu Y., Cheang T.Y., Huang X.L., Wang S.M. MicroRNA-21 regulates vascular smooth muscle cell function via targeting tropomyosin 1 in arteriosclerosis obliterans of lower extremities. Arterioscler. Thromb. Vasc. Biol. 2011, 31:2044-2053.
16. Torella D., Iaconetti C., Catalucci D., Ellison G.M., Leone A., Waring C.D., Bochicchio A., Vicinanza C., Aquila I., Curcio A., Condorelli G., Indolfi C. MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circ. Res. 2011, 109:880-893.
17. Liu X., Cheng Y., Zhang S., Lin Y., Yang J., Zhang C. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ. Res. 2009, 104:476-487.
18. Davis B.N., Hilyard A.C., Nguyen P.H., Lagna G., Hata A. Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J. Biol. Chem. 2009, 284:3728-3738.
19. Li P., Liu Y., Yi B., Wang G., You X., Zhao X., Summer R., Qin Y., Sun J. MicroRNA-638 is highly expressed in human vascular smooth muscle cells and inhibits pdgf-bb-induced cell proliferation and migration through targeting orphan nuclear receptor nor1. Cardiovasc. Res. 2013, 99:185-193.
20. Li P., Zhu N., Yi B., Wang N., Chen M., You X., Zhao X., Solomides C.C., Qin Y., Sun J. MicroRNA-663 regulates human vascular smooth muscle cell phenotypic switch and vascular neointimal formation. Circ. Res. 2013, 113:1117-1127.
21. Cordes K.R., Sheehy N.T., White M.P., Berry E.C., Morton S.U., Muth A.N., Lee T.H., Miano J.M., Ivey K.N., Srivastava D. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009, 460:705-710.
22. Rangrez A.Y., Massy Z.A., Metzinger-Le Meuth V., Metzinger L. miR-143 and miR-145: molecular keys to switch the phenotype of vascular smooth muscle cells. Circ. Cardiovasc. Genet. 2011, 4:197-205.
23. Xin M., Small E.M., Sutherland L.B., Qi X., McAnally J., Plato C.F., Richardson J.A., Bassel-Duby R., Olson E.N. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev. 2009, 23:2166-2178.
24. Boettger T., Beetz N., Kostin S., Schneider J., Kruger M., Hein L., Braun T. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the miR143/145 gene cluster. J. Clin. Invest. 2009, 119:2634-2647.
25. Cheng Y., Liu X., Yang J., Lin Y., Xu D.Z., Lu Q., Deitch E.A., Huo Y., Delphin E.S., Zhang C. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ. Res. 2009, 105:158-166.
26. Zhao N., Koenig S.N., Trask A.J., Lin C.H., Hans C.P., Garg V., Lilly B. MicroRNA miR145 regulates tgfbr2 expression and matrix synthesis in vascular smooth muscle cells. Circ. Res. 2015, 116:23-34.
27. Elia L., Quintavalle M., Zhang J., Contu R., Cossu L., Latronico M.V., Peterson K.L., Indolfi C., Catalucci D., Chen J., Courtneidge S.A., Condorelli G. The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ. 2009, 16:1590-1598.
28. Tarasov V., Jung P., Verdoodt B., Lodygin D., Epanchintsev A., Menssen A., Meister G., Hermeking H. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and g1-arrest. Cell Cycle 2007, 6:1586-1593.
29. Chang T.C., Wentzel E.A., Kent O.A., Ramachandran K., Mullendore M., Lee K.H., Feldmann G., Yamakuchi M., Ferlito M., Lowenstein C.J., Arking D.E., Beer M.A., Maitra A., Mendell J.T. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell 2007, 26:745-752.
30. He L., He X., Lim L.P., de Stanchina E., Xuan Z., Liang Y., Xue W., Zender L., Magnus J., Ridzon D., Jackson A.L., Linsley P.S., Chen C., Lowe S.W., Cleary M.A., Hannon G.J. A microRNA component of the p53 tumour suppressor network. Nature 2007, 447:1130-1134.
31. Raver-Shapira N., Marciano E., Meiri E., Spector Y., Rosenfeld N., Moskovits N., Bentwich Z., Oren M. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell 2007, 26:731-743.
32. Bommer G.T., Gerin I., Feng Y., Kaczorowski A.J., Kuick R., Love R.E., Zhai Y., Giordano T.J., Qin Z.S., Moore B.B., MacDougald O.A., Cho K.R., Fearon E.R. P53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 2007, 17:1298-1307.
33. Corney D.C., Flesken-Nikitin A., Godwin A.K., Wang W., Nikitin A.Y. MicroRNA-34b and microRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res. 2007, 67:8433-8438.
34. Yu X., Zhang L., Wen G., Zhao H., Luong L.A., Chen Q., Huang Y., Zhu J., Ye S., Xu Q., Wang W., Xiao Q. Upregulated sirtuin 1 by miRNA-34a is required for smooth muscle cell differentiation from pluripotent stem cells. Cell Death Differ. 2014.
35. Xiao Q., Zeng L., Zhang Z., Margariti A., Ali Z.A., Channon K.M., Xu Q., Hu Y. Sca-1+ progenitors derived from embryonic stem cells differentiate into endothelial cells capable of vascular repair after arterial injury. Arterioscler. Thromb. Vasc. Biol. 2006, 26:2244-2251.
36. Zeng L., Xiao Q., Margariti A., Zhang Z., Zampetaki A., Patel S., Capogrossi M.C., Hu Y., Xu Q. Hdac3 is crucial in shear- and vegf-induced stem cell differentiation toward endothelial cells. J. Cell Biol. 2006, 174:1059-1069.
37. Xiao Q., Zhang F., Grassia G., Hu Y., Zhang Z., Xing Q., Yin X., Maddaluno M., Drung B., Schmidt B., Maffia P., Ialenti A., Mayr M., Xu Q., Ye S. Matrix metalloproteinase-8 promotes vascular smooth muscle cell proliferation and neointima formation. Arterioscler. Thromb. Vasc. Biol. 2014, 34:90-98.
38. Wang L., Zheng J., Du Y., Huang Y., Li J., Liu B., Liu C.J., Zhu Y., Gao Y., Xu Q., Kong W., Wang X. Cartilage oligomeric matrix protein maintains the contractile phenotype of vascular smooth muscle cells by interacting with alpha(7)beta(1) integrin. Circ. Res. 2010, 106:514-525.
39. Salmon M., Gomez D., Greene E., Shankman L., Owens G.K. Cooperative binding of klf4, pelk-1, and hdac2 to a g/c repressor element in the sm22alpha promoter mediates transcriptional silencing during smc phenotypic switching in vivo. Circ. Res. 2012, 111:685-696.
40. Chahine M.N., Blackwood D.P., Dibrov E., Richard M.N., Pierce G.N. Oxidized ldl affects smooth muscle cell growth through mapk-mediated actions on nuclear protein import. J. Mol. Cell. Cardiol. 2009, 46:431-441.
41. Auge N., Garcia V., Maupas-Schwalm F., Levade T., Salvayre R., Negre-Salvayre A. Oxidized ldl-induced smooth muscle cell proliferation involves the egf receptor/pi-3 kinase/akt and the sphingolipid signaling pathways. Arterioscler. Thromb. Vasc. Biol. 2002, 22:1990-1995.
42. Ong C.T., Cheng H.T., Chang L.W., Ohtsuka T., Kageyama R., Stormo G.D., Kopan R. Target selectivity of vertebrate notch proteins. Collaboration between discrete domains and csl-binding site architecture determines activation probability. J. Biol. Chem. 2006, 281:5106-5119.
43. Liang C.C., Park A.Y., Guan J.L. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protoc. 2007, 2:329-333.
44. Pidkovka N.A., Cherepanova O.A., Yoshida T., Alexander M.R., Deaton R.A., Thomas J.A., Leitinger N., Owens G.K. Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro. Circ. Res. 2007, 101:792-801.
45. Navarro F., Gutman D., Meire E., Caceres M., Rigoutsos I., Bentwich Z., Lieberman J. miR-34a contributes to megakaryocytic differentiation of k562 cells independently of p53. Blood 2009, 114:2181-2192.
46. Clarke M.C., Talib S., Figg N.L., Bennett M.R. Vascular smooth muscle cell apoptosis induces interleukin-1-directed inflammation: effects of hyperlipidemia-mediated inhibition of phagocytosis. Circ. Res. 2010, 106:363-372.
47. Clarke M.C., Littlewood T.D., Figg N., Maguire J.J., Davenport A.P., Goddard M., Bennett M.R. Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration. Circ. Res. 2008, 102:1529-1538.
48. Clarke M.C., Figg N., Maguire J.J., Davenport A.P., Goddard M., Littlewood T.D., Bennett M.R. Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat. Med. 2006, 12:1075-1080.
49. Sweeney C., Morrow D., Birney Y.A., Coyle S., Hennessy C., Scheller A., Cummins P.M., Walls D., Redmond E.M., Cahill P.A. Notch 1 and 3 receptor signaling modulates vascular smooth muscle cell growth, apoptosis, and migration via a cbf-1/rbp-jk dependent pathway. FASEB J. 2004, 18:1421-1423.
50. Redmond E.M., Liu W., Hamm K., Hatch E., Cahill P.A., Morrow D. Perivascular delivery of notch 1 sirna inhibits injury-induced arterial remodeling. PLoS ONE 2014, 9:e84122.
51. Li Y., Takeshita K., Liu P.Y., Satoh M., Oyama N., Mukai Y., Chin M.T., Krebs L., Kotlikoff M.I., Radtke F., Gridley T., Liao J.K. Smooth muscle Notch1 mediates neointimal formation after vascular injury. Circulation 2009, 119:2686-2692.
52. Bu P., Chen K.Y., Chen J.H., Wang L., Walters J., Shin Y.J., Goerger J.P., Sun J., Witherspoon M., Rakhilin N., Li J., Yang H., Milsom J., Lee S., Zipfel W., Jin M.M., Gumus Z.H., Lipkin S.M., Shen X. A microRNA miR-34a-regulated bimodal switch targets notch in colon cancer stem cells. Cell Stem Cell 2013, 12:602-615.
53. Kang J., Kim E., Kim W., Seong K.M., Youn H., Kim J.W., Kim J., Youn B. Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition (emt) by miR-34a-mediated suppression of notch-1 expression in non-small cell lung cancer cell lines. J. Biol. Chem. 2013, 288:27343-27357.
54. Dickson M., Gagnon J.P. Key factors in the rising cost of new drug discovery and development. Nat. Rev. Drug Discov. 2004, 3:417-429.
55. Garcia-Olivas R., Vilaro S., Reina M., Castel S. Pdgf-stimulated cell proliferation and migration of human arterial smooth muscle cells. Colocalization of pdgf isoforms with glycosaminoglycans. Int. J. Biochem. Cell Biol. 2007, 39:1915-1929.
56. Millette E., Rauch B.H., Defawe O., Kenagy R.D., Daum G., Clowes A.W. Platelet-derived growth factor-bb-induced human smooth muscle cell proliferation depends on basic fgf release and fgfr-1 activation. Circ. Res. 2005, 96:172-179.
57. Kingsley K., Huff J.L., Rust W.L., Carroll K., Martinez A.M., Fitchmun M., Plopper G.E. Erk1/2 mediates pdgf-bb stimulated vascular smooth muscle cell proliferation and migration on laminin-5. Biochem. Biophys. Res. Commun. 2002, 293:1000-1006.
58. Tannenbaum J.E., Waleh N.S., Mauray F., Breuss J., Pytela R., Kramer R.H., Clyman R.I. Transforming growth factor beta 1 inhibits fetal lamb ductus arteriosus smooth muscle cell migration. Pediatr. Res. 1995, 37:561-570.
59. Reddy K.B., Howe P.H. Transforming growth factor beta 1-mediated inhibition of smooth muscle cell proliferation is associated with a late g1 cell cycle arrest. J. Cell. Physiol. 1993, 156:48-55.
60. Ueba H., Kawakami M., Yaginuma T. Shear stress as an inhibitor of vascular smooth muscle cell proliferation. Role of transforming growth factor-beta 1 and tissue-type plasminogen activator. Arterioscler. Thromb. Vasc. Biol. 1997, 17:1512-1516.
61. Seay U., Sedding D., Krick S., Hecker M., Seeger W., Eickelberg O. Transforming growth factor-beta-dependent growth inhibition in primary vascular smooth muscle cells is p38-dependent. J. Pharmacol. Exp. Ther. 2005, 315:1005-1012.
62. Halloran B.G., Prorok G.D., So B.J., Baxter B.T. Transforming growth factor-beta 1 inhibits human arterial smooth-muscle cell proliferation in a growth-rate-dependent manner. Am. J. Surg. 1995, 170:193-197.
63. Rokavec M., Li H., Jiang L., Hermeking H. The p53/miR-34 axis in development and disease. J. Mol. Cell Biol. 2014, 6:214-230.
64. Fan F., Sun A., Zhao H., Liu X., Zhang W., Jin X., Wang C., Ma X., Shen C., Zou Y., Hu K., Ge J. MicroRNA-34a promotes cardiomyocyte apoptosis post myocardial infarction through down-regulating aldehyde dehydrogenase 2. Curr. Pharm. Des. 2013, 19:4865-4873.
65. Peng X., Shao J., Shen Y., Zhou Y., Cao Q., Hu J., He W., Yu X., Liu X., Marian A.J., Hong K. Fat10 protects cardiac myocytes against apoptosis. J. Am. Coll. Cardiol. 2013, 59:1-10.
66. Huang J., Sun W., Huang H., Ye J., Pan W., Zhong Y., Cheng C., You X., Liu B., Xiong L., Liu S. miR-34a modulates angiotensin II-induced myocardial hypertrophy by direct inhibition of atg9a expression and autophagic activity. PLoS ONE 2014, 9.
67. Boon R.A., Iekushi K., Lechner S., Seeger T., Fischer A., Heydt S., Kaluza D., Treguer K., Carmona G., Bonauer A., Horrevoets A.J., Didier N., Girmatsion Z., Biliczki P., Ehrlich J.R., Katus H.A., Muller O.J., Potente M., Zeiher A.M., Hermeking H., Dimmeler S. Microrna-34a regulates cardiac ageing and function. Nature 2013, 495:107-110.
68. Emanueli C., Thum T. Mirnage-34 induces cardiac damage. Cell Res. 2013, 23:866-867.
69. Feng Y., Huang W., Meng W., Jegga A.G., Wang Y., Cai W., Kim H.W., Pasha Z., Wen Z., Rao F., Modi R.M., Yu X., Ashraf M. Heat shock improves sca-1+ stem cell survival and directs ischemic cardiomyocytes toward a prosurvival phenotype via exosomal transfer: a critical role for hsf1/miR-34a/hsp70 pathway. Stem Cells 2014, 32:462-472.
70. Matsumoto S., Sakata Y., Suna S., Nakatani D., Usami M., Hara M., Kitamura T., Hamasaki T., Nanto S., Kawahara Y., Komuro I. Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction. Circ. Res. 2013, 113:322-326.
71. Raitoharju E., Lyytikainen L.P., Levula M., Oksala N., Mennander A., Tarkka M., Klopp N., Illig T., Kahonen M., Karhunen P.J., Laaksonen R., Lehtimaki T. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis 2011, 219:211-217.
72. Xu Q., Seeger F.H., Castillo J., Iekushi K., Boon R.A., Farcas R., Manavski Y., Li Y.G., Assmus B., Zeiher A.M., Dimmeler S. Micro-RNA-34a contributes to the impaired function of bone marrow-derived mononuclear cells from patients with cardiovascular disease. J. Am. Coll. Cardiol. 2012, 59:2107-2117.
73. Bernardo B.C., Gao X.M., Winbanks C.E., Boey E.J., Tham Y.K., Kiriazis H., Gregorevic P., Obad S., Kauppinen S., Du X.J., Lin R.C., McMullen J.R. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:17615-17620.
74. Yang K., Lu L., Liu Y., Zhang Q., Pu L.J., Wang L.J., Zhu Z.B., Wang Y.N., Meng H., Zhang X.J., Du R., Chen Q.J., Shen W.F. Increase of adam10 level in coronary artery in-stent restenosis segments in diabetic minipigs: high adam10 expression promoting growth and migration in human vascular smooth muscle cells via notch 1 and 3. PLoS ONE 2013, 8:e83853.
75. Tarantino C., Paolella G., Cozzuto L., Minopoli G., Pastore L., Parisi S., Russo T. miRNA 34a, 100, and 137 modulate differentiation of mouse embryonic stem cells. FASEB J. 2010, 24:3255-3263.
76. Yamakuchi M., Ferlito M., Lowenstein C.J. miR-34a repression of sirt1 regulates apoptosis. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:13421-13426.
77. Wei J., Shi Y., Zheng L., Zhou B., Inose H., Wang J., Guo X.E., Grosschedl R., Karsenty G. miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting satb2. J. Cell Biol. 2012, 197:509-521.
78. Cheng B.B., Qu M.J., Wu L.L., Shen Y., Yan Z.Q., Zhang P., Qi Y.X., Jiang Z.L. MicroRNA-34a targets forkhead box j2 to modulate differentiation of endothelial progenitor cells in response to shear stress. J. Mol. Cell. Cardiol. 2014, 74:4-12.
79. Krzeszinski J.Y., Wei W., Huynh H., Jin Z., Wang X., Chang T.C., Xie X.J., He L., Mangala L.S., Lopez-Berestein G., Sood A.K., Mendell J.T., Wan Y. miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and tgif2. Nature 2014, 512:431-435.
80. Ito T., Yagi S., Yamakuchi M. MicroRNA-34a regulation of endothelial senescence. Biochem. Biophys. Res. Commun. 2010, 398:735-740.
81. Zhao T., Li J., Chen A.F. MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E110-E116.
82. Fan W., Fang R., Wu X., Liu J., Feng M., Dai G., Chen G., Wu G. Shear-sensitive microRNA-34a modulates flow-dependent regulation of endothelial inflammation. J. Cell Sci. 2015, 128:70-80.
83. Jiang P., Liu R., Zheng Y., Liu X., Chang L., Xiong S., Chu Y. miR-34a inhibits lipopolysaccharide-induced inflammatory response through targeting Notch1 in murine macrophages. Exp. Cell Res. 2012, 318:1175-1184.
84. Rodriguez-Ubreva J., Ciudad L., van Oevelen C., Parra M., Graf T., Ballestar E. C/ebpa-mediated activation of microRNAs 34a and 223 inhibits lef1 expression to achieve efficient reprogramming into macrophages. Mol. Cell. Biol. 2014, 34:1145-1157.